Novo Nordisk A/S ADR buy Argus
Start price
02.10.23
/
50%
€85.60
Target price
02.10.24
€104.76
Performance (%)
22.66%
End price
03.10.24
€105.00
Summary
This prediction ended on 03.10.24 with a price of €105.00. The BUY prediction by Argus finished with a performance of 22.66%. Dividends of €1.08 are taken into consideration when calculating the performance. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | 4.015% | 4.015% | -58.088% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Argus for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) is now covered by analysts at Argus. They set a "buy" rating and a $110.00 price target on the stock.
Ratings data for NVO provided by MarketBeat
In the thread Trading Novo Nordisk A/S ADR
Die von Argus gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Argus for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€132.00
10.06.24
10.06.24
€148.83
10.06.25
10.06.25
-47.35%
11.06.25
11.06.25
